WHO naming stem · anywhere in the name · 112 listed names
gli
This page was written with AI.
antihyperglycaemics
Where it sits in a name
WHO writes the stem as gli, without hyphens, which means it can sit anywhere in a name. So the letters gli sit anywhere in the name (gli).
All 112 names WHO lists under gli
These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.
Beside each name: the brand names it appears under in the US list (FDA Drugs@FDA) and the EU central list (EMA), or that neither list carries it. 20 of 112 names appear in these lists: 18 in the US list (FDA Drugs@FDA) and 16 in the EU central list (EMA); 16 have national brands in at least one EU/EEA country. Each brand opens in this site's brand lookup. A name is found when the agency's ingredient name is the same name once salt words such as hydrochloride or sodium are set aside (the list of those words); where WHO's own name carries such a word (estradiol valerate), the agency must write the same words. A spelling that differs only by the INN letter rules (ph for f, y for i) is found too and shown. Under each name that one or more EU/EEA countries authorise under a national brand of their own (through that country's agency, so not in the EU central list), a line now gives the number of those countries and their codes, from EMA's Article 57 data, and opens the country lookup at that name. A name with none of these lines may still be sold elsewhere, or in Europe only under its own generic name.
- adomeglivantNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- aleglitazarNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- alogliptinUS brands: NESINAEU (central) brands: Vipidia
- anagliptinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- atigliflozinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- azemiglitazoneNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- balaglitazoneNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- bexagliflozinUS brands: BRENZAVVYEU (central) brands: none found
- bisegliptinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- camigliboseNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- canagliflozinUS brands: INVOKANAEU (central) brands: Invokana
- carfloglitazarNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- carmegliptinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- cevoglitazarNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ciglitazoneNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- cofrogliptinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- dapagliflozinUS brands: FARXIGAin combination: XIGDUO XR with metformin; QTERN (discontinued in FDA listings) with saxagliptin; QTERNMET XR (discontinued in FDA listings) with metformin + saxagliptin
- darglitazoneNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- denagliptinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- deriglidoleNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- dorzagliatinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- dutogliptinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- edaglitazoneNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- emiglitateNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- empagliflozinUS brands: JARDIANCEin combination: GLYXAMBI with linagliptin; SYNJARDY with metformin; SYNJARDY XR with metformin; TRIJARDY XR with linagliptin + metforminEU (central) brands: Jardiance
- enavoglifozinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- englitazoneNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ertugliflozinUS brands: STEGLATROEU (central) brands: Steglatro
- evogliptinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- farglitazarNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- fasiglifamNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- firuglipelNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- garvagliptinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- gemigliptinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- gliamilideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- glibenclamideUS brands: none foundEU (central) brands: Amglidia
- glibornurideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- glibutimineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- glicaramideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- glicetanileNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- gliclazideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- glicondamideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- glidazamideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- gliflumideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- glimepiridein combination: DUETACT with pioglitazone; AVANDARYL (discontinued in FDA listings) with rosiglitazone
- glipalamideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- glipentideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- glipizideEU (central) brands: none found
- gliquidoneNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- glisamurideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- glisentideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- glisindamideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- glisolamideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- glisoxepideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- gosogliptinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- imegliminNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- imiglitazarNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- indeglitazarNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ingliforibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ipragliflozinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- isaglidoleNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- leriglitazoneNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- licogliflozinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- limiglidoleNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- linagliptinUS brands: TRADJENTAin combination: GLYXAMBI with empagliflozin; JENTADUETO with metformin; JENTADUETO XR with metformin; TRIJARDY XR with empagliflozin + metforminEU (central) brands: Trajenta
- linoglirideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lobeglitazoneNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- luseogliflozinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- managlinat dialanetilNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- meglitinideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- melogliptinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- midaglizoleNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- miglitolEU (central) brands: none found
- mitiglinideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- mizagliflozinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- muroglitazarNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- naglivanNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- nateglinide
- naveglitazarNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- netoglitazoneNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- omarigliptinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- oxeglitazarNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- peliglitazarNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pemaglitazarNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pioglitazoneUS brands: ACTOSin combination: ACTOPLUS MET with metformin; DUETACT with glimepiride; OSENI with alogliptin; ACTOPLUS MET XR (discontinued in FDA listings) with metforminEU (central) brands: Actos, Pioglitazone Accord, Pioglitazone Actavis, Glidipion (withdrawn), Glustin (withdrawn), Paglitaz (lapsed), Pioglitazone Krka (withdrawn), Pioglitazone Teva (withdrawn), Pioglitazone Teva Pharma (withdrawn), Sepioglin (withdrawn)
- piragliatinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- piroglirideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- prusogliptinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ragaglitazarNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- reglitazarNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- remogliflozin etabonateNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- repaglinideEU (central) brands: Enyglid, NovoNorm, Prandin, Repaglinide Krka, Repaglinide Teva, Repaglinide Accord (withdrawn)
- rivoglitazoneNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- rosiglitazone
- saroglitazarNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- saxagliptinin combination: KOMBIGLYZE XR (discontinued in FDA listings) with metformin; QTERN (discontinued in FDA listings) with dapagliflozin; QTERNMET XR (discontinued in FDA listings) with dapagliflozin + metforminEU (central) brands: Onglyzain combination: Komboglyze with metformin; Qtern with dapagliflozin; Qtrilmet (withdrawn) with dapagliflozin + metformin
- seglitideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- sergliflozin etabonateNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- sipoglitazarNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- sitagliptinin combination: JANUMET with metformin; JANUMET XR with metformin; STEGLUJAN with ertugliflozin; ZITUVIMET with metformin; ZITUVIMET XR with metformin; JUVISYNC (discontinued in FDA listings) with simvastatinin combination: Efficib with metformin; Janumet with metformin; Ristfor with metformin; Sitagliptin / Metformin hydrochloride Mylan with metformin; Sitagliptin / Metformin hydrochloride Sun with metformin; Steglujan with ertugliflozin; Velmetia with metformin; Sitagliptin / Metformin hydrochloride Accord (lapsed) with metformin
- sodelglitazarNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- sotagliflozinUS brands: INPEFA
- teglicarNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- teneligliptinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tesaglitazarNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tibegliseneNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tofogliflozinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- trelagliptinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- troglitazoneEU (central) brands: none found
- velagliflozinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vildagliptinUS brands: none foundin combination: Eucreas with metformin; Icandra with metformin; Vildagliptin / Metformin hydrochloride Accord with metformin; Zomarist with metformin
- vogliboseNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
US list: Drugs@FDA, from the FDA Drugs@FDA data (openFDA bulk file), checked . It keeps discontinued brands, marked here as FDA marks them.
EU (central) list: EMA medicines list, European Medicines Agency (EMA), checked . Medicines authorised for the whole EU through EMA only: a brand authorised by one country's own agency is not in it. Source: European Medicines Agency (EMA), medicines list, checked 2026-09-24.
EU/EEA national lists: European Medicines Agency (EMA), Article 57 product data, downloaded (EMA's Article 57 page). Brand names authorised by each country's own agency, as the country lookup reads them; a product named after its substance and maker ("Paracetamol Teva") is not counted as a brand, and EU central authorisations are not counted as a country. GB in a list is Northern Ireland, which EMA's data carries alongside the EU/EEA countries.
Names with these letters that are not antihyperglycaemics
WHO lists these 6 names under gli, but says the stem is not used in its meaning here: group (b) of Part IV of the 2024 stem book, “INN in which the preferred stem has been used, but not in accordance with its definition”. The letters are marked where they sit; WHO’s note, where it gives one, is quoted as written. In these names, WHO’s definition of gli does not apply.
- cromoglicate lisetil
- cromoglicic acid
- ioglicic acid
- ioxaglic acid
- sulglicotide
- tropigline
Same group, without the stem
WHO also lists these 12 names under gli: group (c) of Part IV of the 2024 stem book, “INN which belong to the same group of pharmaceutical substances but in which the stem is not used”. They belong to the same group of substances as the group (a) names above, yet they do not carry gli, so the name alone does not reveal the group.
- acetohexamide
- butadiazamide
- carbutamide
- chlorpropamide
- heptolamide
- metahexamide
- palmoxiric acid
- thiohexamide
- tolazamide
- tolbutamide
- tolpentamide
- tolpyrramide
Decode another name
Decoded
miglitol
Listed INNCarries the WHO stem gli
- gliinside the nameWHO lists it hereWHO definition: antihyperglycaemics
“miglitol” is an INN that WHO lists under gli in the 2024 stem book.
The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.
Source and licence
The definition of gli (Part II B) and the 112 names (Part IV, group (a)), and the 6 not in accordance with it (group (b)) and 12 of the same group without the stem (group (c)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .
Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.